Table 2.

Per-patient sensitivity and specificity for metastatic disease

	Patients with metastatic disease*	Sensitivity				Patients without metastatic disease*	Specificity
		WB-MRI staging pathway†	Standard staging pathway	Difference	p value		WB-MRI staging pathway†	Standard staging pathway	Difference	p value
Diagnostic accuracy	52	50% (37 to 63)	54% (41 to 67)	−4% (−15 to 7)	p=0·73	135	93% (88 to 96)	95% (91 to 98)	−2% (−7 to 2)	p=0·45
Equivocal lesions considered negative	52	48% (35 to 61)	46% (33 to 59)	2% (−11 to 14)	..	135	94% (89 to 97)	97% (93 to 99)	−3% (−6 to 1)	..

Data are n or % (95% CI).

^*Patients by consensus reference standard.

^†WB-MRI plus additional generated tests.